- Home
- IGMS vs NEGG Comparison
IGMS vs NEGG Comparison
Compare IGMS & NEGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGMS
- NEGG
- Stock Information
- Founded
- IGMS 1993
- NEGG 2001
- Country
- IGMS United States
- NEGG United States
- Employees
- IGMS N/A
- NEGG N/A
- Industry
- IGMS Biotechnology: Pharmaceutical Preparations
- NEGG Other Specialty Stores
- Sector
- IGMS Health Care
- NEGG Consumer Discretionary
- Exchange
- IGMS Nasdaq
- NEGG Nasdaq
- Market Cap
- IGMS 82.1M
- NEGG 75.6M
- IPO Year
- IGMS 2019
- NEGG 2010
- Fundamental
- Price
- IGMS $1.13
- NEGG $4.11
- Analyst Decision
- IGMS Hold
- NEGG
- Analyst Count
- IGMS 8
- NEGG 0
- Target Price
- IGMS $6.14
- NEGG N/A
- AVG Volume (30 Days)
- IGMS 155.8K
- NEGG 34.7K
- Earning Date
- IGMS 05-20-2025
- NEGG 04-28-2025
- Dividend Yield
- IGMS N/A
- NEGG N/A
- EPS Growth
- IGMS N/A
- NEGG N/A
- EPS
- IGMS N/A
- NEGG N/A
- Revenue
- IGMS $2,679,000.00
- NEGG $1,235,576,000.00
- Revenue This Year
- IGMS $121.76
- NEGG N/A
- Revenue Next Year
- IGMS $46.83
- NEGG N/A
- P/E Ratio
- IGMS N/A
- NEGG N/A
- Revenue Growth
- IGMS 25.77
- NEGG N/A
- 52 Week Low
- IGMS $0.92
- NEGG $3.32
- 52 Week High
- IGMS $22.50
- NEGG $26.40
- Technical
- Relative Strength Index (RSI)
- IGMS 39.53
- NEGG 47.29
- Support Level
- IGMS $1.11
- NEGG $3.40
- Resistance Level
- IGMS $1.40
- NEGG $3.99
- Average True Range (ATR)
- IGMS 0.11
- NEGG 0.31
- MACD
- IGMS -0.01
- NEGG 0.13
- Stochastic Oscillator
- IGMS 5.56
- NEGG 89.77
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.